Found: 7
Select item for more details and to access through your institution.
Physician preferences for non-metastatic castration-resistant prostate cancer treatment.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Patient-level Factors Associated With the Initial Management of Older Adults Diagnosed With Follicular Lymphoma: A Surveillance, Epidemiology, and End Results-Medicare Analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Costs and Healthcare Resource Utilization Associated with Hospital Admissions of Patients with Metastatic or Nonmetastatic Prostate Cancer.
- Published in:
- American Health & Drug Benefits, 2019, v. 12, n. 6, p. 306
- By:
- Publication type:
- Article
Clinical outcomes, management, and treatment patterns in patients with metastatic castration‐resistant prostate cancer treated with radium‐223 in community compared to academic settings.
- Published in:
- Prostate, 2021, v. 81, n. 10, p. 657, doi. 10.1002/pros.24143
- By:
- Publication type:
- Article
Clinical outcomes, management, and treatment patterns in patients with metastatic castration‐resistant prostate cancer treated with radium‐223 in community compared to academic settings.
- Published in:
- Prostate, 2021, v. 81, n. 10, p. 657, doi. 10.1002/pros.24143
- By:
- Publication type:
- Article
Patient and caregiver benefit‐risk preferences for nonmetastatic castration‐resistant prostate cancer treatment.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 18, p. 6586, doi. 10.1002/cam4.3321
- By:
- Publication type:
- Article
Real-world burden of adverse events for apalutamide- or enzalutamide-treated non-metastatic castration-resistant prostate cancer patients in the United States.
- Published in:
- 2022
- By:
- Publication type:
- journal article